Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Novogen Patent Covering Cantrixil and Trilexium Accepted in Australia 2015-11-12 08:04
Novogen Applies for Long-term Options Listing 2015-09-30 10:52
Novogen Announces The Outcome Of A Comprehensive Science Review 2015-08-31 07:00
Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2015-07-30 08:08
Novogen Appoints Iain Ross as Acting CEO and Re-appoints Him to the Board 2015-07-22 10:34
Anisina Receives Orphan Drug Designation from FDA for Neuroblastoma 2015-07-16 15:37
Pre-clinical Studies Suggest Anisina May Improve Chemotherapy Effectiveness in Childhood Cancer 2015-07-14 07:00
Novogen Announces the Chairman's Address at the Company's General Meeting 2015-06-24 10:54
Anisina on Track to Enter Clinic in 2016 2015-06-24 08:00
Novogen to Present at Bio International Convention Philadelphia 2015 2015-06-12 12:15
Studies Confirm TRXE-009 Crosses the Blood-brain Barrier 2015-06-05 07:30
Novogen Expands Board with Two New Appointments 2015-06-03 09:20
Novogen Limited Announces Closing of Rights Issue Entitlement Offer and Notice of Shortfall 2015-06-02 11:47
ATM Technology Extended with New Patent Lodgement 2015-05-28 10:02
Novogen to Present at Brain Tumor Biotech Summit 2015 2015-05-27 06:00
Novogen to Present at the 2015 Marcum Microcap Conference 2015-05-26 08:28
Novogen to Present at Hong Kong Investor Conference 2015-05-18 09:08
Anisina Confirmed as Effective Anti-Cancer Agent in Animal Studies 2015-05-14 09:39
Australian Studies Confirm TRXE-009 Kills Resistant Paediatric Brain Cancer Cells 2015-05-08 06:54
Novogen Completes the Private Placement of Equity 2015-04-29 15:32
1 2 3